Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives. 438 testimonials and most are 5 stars. Nothing to lose with our FREE 2-week trial .Analyst’s Disclosure: I/we have a beneficial long position in the shares of PEP, CP, DHR, REXR either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Se ...

Danaher Corporation (NYSE:DHR) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 3:25 PM ET Company Participants Rainer Blair - President and CEO Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Great. Thanks, everyone, for joining us this afternoon. I'm Vijay Kumar, the Life Science Device Analyst at Evercore. A pleasure to have with us the team from Danaher. We have CEO, Rainer Blair and we have, I think, Travis, -- as well as Travis and John in out there . So, Raine ...

Danaher Corporation (NYSE:DHR) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 3:25 PM ET Company Participants Rainer Blair - President and CEO Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Great. Thanks, everyone, for joining us this afternoon. I'm Vijay Kumar, the Life Science Device Analyst at Evercore. A pleasure to have with us the team from Danaher. We have CEO, Rainer Blair and we have, I think, Travis, -- as well as Travis and John in out there . So, Raine ...

WASHINGTON, Nov. 26, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conference in Coral Gables, Florida on Wednesday, December 4, 2024 at 3:25 p.m. ET. The event will be simultaneously webcast on www.danaher.com.ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our ...

Have you evaluated the performance of Danaher's (DHR) international operations during the quarter that concluded in September 2024? Considering the extensive worldwide presence of this industrial and medical device maker, analyzing the patterns in international revenues is crucial for understanding its financial resilience and potential for growth. In the current global economy, which is more interconnected than ever, a company's success in penetrating international markets is crucial for its financial heal ...

On Tuesday, Danaher Corp DHR reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. Guidance: Danaher reaffirms that in fiscal year 2024, non-GAAP core revenue will be down in the low single digits year over year. The company forecasts that 2024 bioprocessing core revenue will decline in the low single digits, and Cepheid 2024 respiratory revenues will be around $1.7 billion compared to prior guidance of $1.6 billion. William Blair reports that Danaher's ...

Danaher Corporation’s (DHR) third-quarter 2024 adjusted earnings (excluding 59 cents from non-recurring items) of $1.71 per share surpassed the Zacks Consensus Estimate of $1.56. The bottom line declined 0.6% year over year.Danaher’s reported net sales of $5.8 billion, which beat the consensus estimate of $5.6 billion. The metric increased 3.1% year over year, driven by robust sales in the Diagnostics and Life Sciences segments.DHR’s core sales increased 0.5%. Acquisitions had a positive impact of 2.5% on q ...

Tuesday, October 22nd, 2024 Following a week or two of seemingly higher and higher all-time closing highs, we see something of a pullback in stock market activity in the first two trading days of this week. There aren't any concrete reasons behind this — no economic data or dire Q3 reports impacting market sentiment — but more a cautious foreboding of what may be to come. The possible explanations for this are manifold. High market valuations naturally bring about caution, and in two weeks we potentially co ...

Danaher Corporation (NYSE:DHR) Q3 2024 Earnings Call Transcript October 22, 2024 8:00 AM ET Company Participants John Bedford - VP of IR Rainer Blair - President and CEO Matt McGrew - EVP and CFO Conference Call Participants Tycho Peterson - Jefferies Michael Ryskin - Bank of America Doug Schenkel - Wolfe Research Vijay Kumar - Evercore ISI Scott Davis - Melius Research Puneet Souda - Leerink Partners Dan Leonard - UBS Jack Meehan - Nephron Research Operator My name is Ashley and I will be your conference f ...

For the quarter ended September 2024, Danaher (DHR) reported revenue of $5.8 billion, down 15.6% over the same period last year. EPS came in at $1.71, compared to $2.02 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $5.59 billion, representing a surprise of +3.65%. The company delivered an EPS surprise of +9.62%, with the consensus EPS estimate being $1.56. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how t ...